NCT02355704 - Anti-inflammatory Effect of Atorvastatin on Graft Donor Kidney | Biotech Hunter

Enrollment

48

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

July 31, 2014

Conditions

Renal Insufficiency

Interventions

DRUG

Atorvastatin

Patients were assigned to two groups, one of them received oral atorvastatin (study group) and the other, homologated placebo (control group) for 4 weeks before a kidney transplantation. Previous surgical procedure controls were performed

DRUG

Placebo

Patients were assigned to two groups, one of them received oral atorvastatin (study group) and the other, homologated placebo (control group) for 4 weeks before a kidney transplantation. Previous surgical procedure were performed

Trial Locations (1)

44340

Western Medical Center, Mexican Institute of Social Security, Guadalajara